Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2008 Feb 15;18(4):1297-303. Epub 2008 Jan 11.

    Identification of a potent new chemotype for the selective inhibition of PDE4.

    Source

    NIH Chemical Genomics Center, National Human Genome Research Institute, NIH, 9800 Medical Center Drive, MSC 3370, Bethesda, MD 20892-3370, USA.

    Abstract

    A series of substituted 3,6-diphenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines were prepared and analyzed as inhibitors of phosphodiesterase 4 (PDE4). Synthesis, structure-activity relationships, and the selectivity of a highly potent analogue against related phosphodiesterase isoforms are presented.

    PMID:
    18243697
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2268978
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 2
    Scheme 1
    Figure 1
    Figure 3

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk